Regencell Bioscience Holdings (RGC) Other Non-Current Assets (2020 - 2025)

Regencell Bioscience Holdings has reported Other Non-Current Assets for 6 years, with the latest figure at $93439.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Non-Current Assets changed N/A year-over-year to $93439.0; the trailing twelve-month figure through Dec 2025 stood at $93439.0 (changed N/A YoY), and the FY2025 full-year result was $92950.0, down 4.85% from the prior year.
• Other Non-Current Assets for Q4 2025 stood at $93439.0, up from $92950.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $114302.0 in Q2 2022, with the low at $19106.0 in Q2 2021.
• Historically, Other Non-Current Assets has averaged $87663.3 across 5 years, with a median of $95561.5 in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 498.25% — and 2024, when it decreased 9.97%.
• Regencell Bioscience Holdings' Other Non-Current Assets stood at $19106.0 in 2021, then jumped by 498.25% to $114302.0 in 2022, then slipped by 5.08% to $108499.0 in 2023, then declined by 9.97% to $97684.0 in 2024, then decreased by 4.35% to $93439.0 in 2025.
• The last three Other Non-Current Assets figures came in at $93439.0 (Q4 2025), $92950.0 (Q2 2025), and $97684.0 (Q2 2024), per Business Quant data.